How to Be a Super Ager (with Eric Topol)
EconTalk
00:00
Innovations and Challenges in Vaccine and Genetic Health
This chapter examines the stagnation of vaccine innovation due to intellectual property issues and the commitment to mass production, while also highlighting promising advanced technologies that remain underutilized. It also discusses polygenic risk scores and their importance in genetic predisposition assessment, alongside the implications of personalized health decisions based on these scores. The chapter critiques current preventive health approaches and advocates for personalized strategies to improve early detection and health outcomes, emphasizing the role of advanced diagnostics and lifestyle choices.
Transcript
Play full episode
